This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

PDF
Markdown

2022-09-30-accounts

			Page
Contents			Numbers
Legal and	administrative	information
Report of	the Trustees		3-10
Report of	the Auditors		11-13
Statement	offinancial	activities	14
Charity balance sheet			15
Notes forming part ofthe financial statements			16-24

Charity registration	Charity registration	number: 1129597	number: 1129597
Company	registration		number: 6876186
Directors	and
Trustees:			Dr Kevin Moreton		24/11/15 —present
			Dr Jan Lowe		17/05/18 —present
			Dr Liz Miller		13/08/18 —present
			Dr LeoJames		28/03/19 —present
			Dr Anne Bertolotti		05/11/20 —present
Secretary:			Mrs Josie Gowler FCA		18/04/18 —present
Registered			MRC Laboratory ofMolecular	Biology
Office:			Francis Crick Avenue
			Cambridge Biomedical Campus
			Cambridge
			CB2 OQH
Auditors:			Price Bailey LLP:
			Tennyson House
			Cambridge Business Park
			Cambridge
			CB4OWZ
Bankers:			Lloyds Bank PLC:
			3Sidney Street
			Cambridge
			CB238tJ
Solicitors:			Harrison Clark Rickerbys Limited:
			50-60Station Road
			Cambridge
			CB12JH

						Total Year	Total Year
					Expendable	01/10/21	01/10/20
			Unrestricted	Restncted	Endowment	to	to
			Funds	Funds	Funds	30/09/22	30/09/21
		Note	f	E	f	f	E
Income:
Donations and legacies		3	28,701	35,506	0	64,207	216,440
Investment Income		4	90,559	47,657	16,790	155,006	126,253
Trading income		14	172	0	0	172	169
Total Income			119,432	83,163	16,790	219,385	342,862
Expenditure on:
Charitable Activities			70,905	21,856		92,761	54,418
Trading Activities			3	0		3	38
Total Expenditure		5	70,908	21,856		92,764	54,456
Net Gains/(Losses)
on Investments			(201,377)	(105,985)	(37,339)	(344,701)	608,428
Net (Expenditure)	/
Income			(152,853)	(44,678)	(20,549)	(218,080)	896,834
Transfers between	funds
Net movement in funds			(152,853)	(44,678)	(20,549)	(218,080)	896,834
Fund Balances
brought forward at
01October 2021			2,031,465	1,032,144	368,443	3,432,052	2,535,218
Fund Balances
carried forward at
30September 2022			1,878,612	987,466	34 .894	3.213.9 2	3,432.052

					30/09/2022	30/09/2021
				Notes	E	E
Fixed Assets
Investments					2,852,106	2,896,807
TOTAL FIXEDASSETS					2,852,106	2,896,807
Current Assets
Debtors: amounts	falling		due within one year	10	560	119,060
Cash at bank and in		hand			382,021	429,539
TOTAL CURRENT ASSETS					382,581	548,599
Creditors: amounts		falling due within one year			(20,715)	(13,354)
Net current assets					361,866	535,245
Net Assets					3,213,972	3,432,052
Funds ofthe charity
Unrestricted Funds
General Funds					1,020,607	1,096,930
Designated Funds					858,005	934,535
					1,878,612	2,031,466
Restricted Funds
Restricted Funds					987,466	1,032,144
Expendable Endowment			Funds		347,894	368,443
					1,335,360	1,400,588
Total Funds				12	3,213,972	3,432,052

Donations	and legacies
		Totalforthe	Total for the
		Year	Year
		01/10/2021 to	01/10/2020 to
		30/09/2022	30/09/2021
		E	E
Individuals		10,641	80,448
Legacies		0	100,000
Gift Aid		560	19,073
Corporate	Donors	53,006	16,919
		64,207	216,440

Investmen	t Income
		Total for the	Total forthe
		Year	Year
		01/10/2021 to	01/10/2020 to
		30/09/2022	30/09/2021
		E	E
Interest Receivable		8	18
Dividends	received from Investments	154,998	126,235
		155,006	126,253

				Activites	Support
				Undertaken	Costs	Total
				Directly	(Note 6)	Funds
				E	E	E
Promotion	and advancement		of
education	and research			84,816	7,945	92,761
Trading activities				3	0	3
				84,819	7,945	92,764
Analysis ofExpenditure		-Prior Year
				Activites	Support
				Undertaken	Costs	Total
				Directly	(Note 6)	Funds
				E	E	E
Promotion	and advancement		of
education	and research			48,620	5,798	54,418
Trading activities				38	0	38
				48,658	5,798	54,456

Analysis	of	Suppor	t Co	sts
					Totalforthe	Totalforthe
					Year	Year
					01/10/2021 to	01/10/2020
					30/09/2022	to 30/09/2021
					E
Professional		Fees			1,621	1,308
Bank Fees					168	169
Trustee	Indemnity		Insurance		967	912
Accountancy		Services			13	13
Governance		Costs	(See	note 7)	5,176	3,396
					7,945	5,798
Analysis	of	Governance		Costs
					Total for the	Total for the
					Year	Year
					01/10/2021 to	01/10/2020
					30/09/2022	to 30/09/2021
					E	E
Audit Fees					,»6	3,396
Trustees'	remuneration

			Total for the	Total for the
			Year	Year
			01/10/2021 to	01/10/2020
			30/09/2022	to 30/09/2021
			E	E
Market value as at 1stOctober			2,896,807	2,188,379
Additions			300,000	100,000
Disposal Proceeds			0	0
Net investments gains / (losses)			(344,701)	608,428
Market value as at 30th September			2,852,106	2,896,807
Historical	cost as at 30th September		2,590,854	2,290,854
UK listed investments are represented		by;
Investment	trusts and unit trusts		2,852,106	2,896,807
			2,852,106	2,896,807

								Totalforthe	Total for the
								Year	Year
								01/10/2021 to	01/10/2020
								30/09/2022	to 30/09/2021
								E	E
Gift aid accrued income								560	19,060
Legacy	accrued income							0	100,000
								560	119,060
11 Creditors:		amounts	falling due within	one year
								Totalforthe	Total for the
								Year	Year
								01/10/2021 to	01/10/2020
								30/09/2022	to 30/09/2021
								E	E
Accrual	s							20,715	13,354
12a Statement		of Funds	—current year
								Investment
			At			Transfers		Gains/	At
			01/10/2021	Income	Expenditure	In/Out		(Losses)	30/09/2022
			E		E			E	E
General Fund			1,096,930	57,084	(23,866)			(109,541)	1,020,607
Designated Funds
Perutz Fund			331,290	15,819	(1,500)			(33,499)	312,110
Milstein Fund			597,302	25,224	(43,781)			(56,096)	522,649
AstraZeneca
Lecture Series			3,876	21,008	(1,761)			(2,241)	20,882
Michael
Neuberger
Studentship			2,067	297					2,364
Total
Unrestricted	funds		2,031,465	119,432	(70,908)			(201,377)	1,878,612
Restricted funds
Steitz (formerly		Brenner)
Postdoc Prize			11,138	34,341	(14,836)			(2,970)	27,673
Sangamo Aaron		King
Symposium			10,497	173	(6,697)			(385)	3,588
GSA/PALFund			0	2,606	(178l			(236)	2,192
Jeantet
Ramakrishnan			363,621	16,564	(145)			(36,836)	343,204
Ieantet Winter			646,888	29,479	0			(65,558)	610,809
			1,032,144	83,163	(21,856)			(105,985)	987,466
Expendable
Endowments
Agouron			254,979	11,619				l25,840)	240,758
Grigg Fund			113,464	5,171				(11,499)	107,136
			368,443	16,790				(37,339)	347,894
Total
restricted funds			1,400,588	99,953	l21,856)			(143,324)	1,335,360
Totalfunds			3,432,052	219,385	(92,764)		0	(344,701)	3,213,972

							Investment
			At			Transfers	Gains/	At
			01/10/2020	Income	Expenditure	In/Out	(Losses)	30/09/2021
			E	E	E	E	E	E
General Fund			682,594	237,960	(5,775)		182,151	1,096,930
Designated	Funds
Perutz Fund			258,184	13,576	(1,001)	0	60,531	331,290
Milstein Fund			499,477	22,643	(33,952)	0	109,134	597,302
AstraZeneca
Lecture Series			3,020	148			708	3,876
Michael
Neuberger
Studentship			2,067				0	2,067
Total
Unrestricted	funds		1,445,342	274,327	(40,729)	0	352,524	2,031,465
Restricted funds
Steitz (formerly		Brenner)
Postdoc Prize			5,929	15,863	(12,689)	0	2,035	11,138
Sangamo Aaron		Klug
Symposium			8,181	398		0	1,918	10,497
Jeantet
Ramakrishnan			284,438	13,784	(1,039)	0	66,438	363,621
Jeantet Winter			504,171	24,523	0	0	118,194	646,888
			802,719	54,568	(13,728)	0	188,585	1,032,144
Expendable
Endowments
Agouron			198,725	B,eee			46,588	254,979
Grigg Fund			88,432	4,301			20,731	113,464
			287,157	13,967			67,319	368,443
Total
restricted funds			1,089,876	68,535	(13,728)	0	255,904	1,400,588
Totalfunds			2,535,218	342,862	(54,456)	0	808,428	3,432,0 2

						Expendable
			General	Designated	Restricted	Endowments	Total
			Funds	Funds	Funds	Funds	Funds
			E	E	E	E	E
Investments			905,695	761,401	876,286	3DB,724	2,852,106
Current	Assets		127,229	104,824	111,358	39,170	382,581
Current	Liabilities		(12,317)	(8,220)	(178)	0	(20,715)
Net Assets		at
30September 2022							3,213,972
13b		Analysis	of Net Assets	between Funds - prior year
						Expendable
			General	Designated	Restricted	Endowments	Total
			Fullds	Funds	Funds	Funds	Funds
			f	f	E	E	E
Investments			925,858	788,789	871,176	31D,982	2,896,807
Current	Assets		174,476	152,895	163,768	57,461	548,600
Current	I iabilities		(3,404)	(7,150)	(2,800)	0	(13,354)
Net Assets		at
30September 2022			1,096,930	934,535	1,032,144